Compare Abeona Therapeutics Inc (ABEO) vs Comfort Systems USA Inc (FIX) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Comfort Systems USA Inc — how do they compare? Abeona Therapeutics Inc trades at $6.72 (market cap $373.32M), while Comfort Systems USA Inc trades at $1,668.78 (market cap $59.26B). The key difference: Comfort Systems USA Inc is far larger — about 158.7× Abeona Therapeutics Inc's market cap, and Comfort Systems USA Inc pays a 0.15% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | FIX | |
|---|---|---|
Market Cap | $373.32M | $59.26B |
Sector | Health | Technology |
52-Week High | $7.23 | $2.07K |
52-Week Low | $4.17 | $527.42 |
Enterprise Value | $228.22M | $58.55B |
Dividend Yield | — | 0.15% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
Comfort Systems USA (FIX) trades at $1,793.03, up 2.97% with strong earnings momentum as Q1 2026 EPS of $10.51 beat expectations of $6.81. The stock shows bearish technical signals but maintains robust fundamentals with 2025 revenue of $9.10B and net income of $1.02B. Recent news highlights leadership transitions and data center cooling demand driving growth.
Outlook remains positive with analyst consensus price target of $2,080 representing 16% upside potential. Key risks include execution challenges from record backlog and competitive pressures in HVAC infrastructure. The company's strong cash flow generation supports dividend payments and strategic acquisitions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Comfort Systems USA Inc
Comfort Systems USA is a premier provider of mechanical and electrical contracting services. It specializes in HVAC, plumbing, and energy management solutions for commercial and industrial facilities.
Read more on FIX →
